BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34866525)

  • 1. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Ren Z; Hu Y; Sun J; Kang Y; Li G; Zhao H
    Bioengineered; 2022 Apr; 13(4):7963-7973. PubMed ID: 35356854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
    Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA DLGAP1-AS1 promotes cell proliferation in hepatocellular carcinoma via sequestering miR-486-5p.
    Peng X; Wei F; Hu X
    J Cell Biochem; 2020 Feb; 121(2):1953-1962. PubMed ID: 31633236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
    Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
    Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
    Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
    J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
    Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
    Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.
    Wang J; Xu J; Zheng J
    Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
    Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
    Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A; Wang J
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
    Liu L; Li X; Shi Y; Chen H
    Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WTAP-mediated m
    Li ZX; Zheng ZQ; Yang PY; Lin L; Zhou GQ; Lv JW; Zhang LL; Chen F; Li YQ; Wu CF; Li F; Ma J; Liu N; Sun Y
    Cell Death Differ; 2022 Jun; 29(6):1137-1151. PubMed ID: 34999731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
    Nong Q; Yu S; Hu H; Hu X
    Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
    Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
    J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
    Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
    Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression.
    Zhou X; Chang Y; Zhu L; Shen C; Qian J; Chang R
    Bioengineered; 2021 Dec; 12(2):10849-10861. PubMed ID: 34634995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.